Skip to main navigation Skip to search Skip to main content

Apoptosis induced in L1210 leukaemia cells by an inhibitor of the chymotrypsin-like activity of the proteasome

  • C. Wójcik
  • , T. Stoklosa
  • , A. Giermasz
  • , J. Golab
  • , R. Zagozdzon
  • , J. Kawiak
  • , S. Wilk
  • , A. Komar
  • , A. Kaca
  • , J. Malejczyk
  • , M. Jakóbisiak

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Of a number of factors involved in apoptosis, protease activity may play a crucial role. We show that N-benzyloxycarbonyl-IIe-Glu(O-t-butyl)-Ala-leucinal (PSI), a selective inhibitor of the chymotrypsin-like activity of the proteasome, induces massive apoptosis in murine leukaemia L1210 cells. At 50 nM concentration, PSI induces a block of cytokinesis, while higher concentrations (500 nM) cause S phase block and massive apoptosis. Z-Leu-leucinal, a specific calpain inhibitor, did not induce apoptosis. In contrast to previous reports, TNF-α did not enhance apoptosis when combined with PSI. Our results suggest that proteasome inhibitors may be considered as potential anti-neoplastic agents.

Original languageEnglish
Pages (from-to)455-462
Number of pages8
JournalApoptosis
Volume2
Issue number5
DOIs
StatePublished - 1997
Externally publishedYes

Keywords

  • Apoptosis
  • Experimental cancer therapy
  • L1210 leukaemia
  • Proteasome, proteasome inhibitor, TNF

Fingerprint

Dive into the research topics of 'Apoptosis induced in L1210 leukaemia cells by an inhibitor of the chymotrypsin-like activity of the proteasome'. Together they form a unique fingerprint.

Cite this